CTAG1B and hepatocellular carcinoma: More specifically in HCC patients, we and other research groups have demonstrated the presence of MAGEA1-, MAGEA10-, MAGEC2-, and NY-ESO-1-specific T-cells, both in blood and in tumors [28,29,30,31,32].